Tools to Identify People At Risk or Already Infected with HIV and HCV

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Spain

Maria J. Vivancos-Gallego, Madrid, Madrid

Sponsor

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Collaborators

Consorcio Centro de Investigación Biomédica en Red (CIBER), European Union

Enrollment target

~240,000 participants

Started

July 2023

Primary completion

January 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

14 Years – 65 Years

Last updated March 2025